Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy

<p>Abstract</p> <p>Autologous stem cell transplantation (ASCT) is the gold standard therapy for suitable multiple myeloma (MM) patients after induction with high dose therapy. To date, the evidence of a reliable marker of prognosis in these cases remains scarce. Our aim was to eval...

Full description

Bibliographic Details
Main Authors: Guimarães Cristina, Bergantim Rui, Ramalho Renata, Couto Nuno, Guimarães João T, Trigo Fernanda
Format: Article
Language:English
Published: BMC 2012-06-01
Series:Journal of Hematology & Oncology
Subjects:
Online Access:http://www.jhoonline.org/content/5/1/33
id doaj-523deee6c3354caf8e5f57bb3ecb9656
record_format Article
spelling doaj-523deee6c3354caf8e5f57bb3ecb96562020-11-24T22:03:22ZengBMCJournal of Hematology & Oncology1756-87222012-06-01513310.1186/1756-8722-5-33Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapyGuimarães CristinaBergantim RuiRamalho RenataCouto NunoGuimarães João TTrigo Fernanda<p>Abstract</p> <p>Autologous stem cell transplantation (ASCT) is the gold standard therapy for suitable multiple myeloma (MM) patients after induction with high dose therapy. To date, the evidence of a reliable marker of prognosis in these cases remains scarce. Our aim was to evaluate appearance of unrelated atypical serum immunofixation patterns (ASIPs) as a marker of prognosis in MM patients submitted to ASCT. We retrospectively analysed data from 65 patients. Interestingly, we observed that presence of ASIPs was associated with longer progression-free survival and longer overall survival. Our results suggested that presence of ASIPs could be a novel marker of good prognosis in MM patients submitted to ASCT.</p> http://www.jhoonline.org/content/5/1/33Multiple myelomaAutologous stem cell transplantationMarker of prognosisSerum immunofixation patterns
collection DOAJ
language English
format Article
sources DOAJ
author Guimarães Cristina
Bergantim Rui
Ramalho Renata
Couto Nuno
Guimarães João T
Trigo Fernanda
spellingShingle Guimarães Cristina
Bergantim Rui
Ramalho Renata
Couto Nuno
Guimarães João T
Trigo Fernanda
Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy
Journal of Hematology & Oncology
Multiple myeloma
Autologous stem cell transplantation
Marker of prognosis
Serum immunofixation patterns
author_facet Guimarães Cristina
Bergantim Rui
Ramalho Renata
Couto Nuno
Guimarães João T
Trigo Fernanda
author_sort Guimarães Cristina
title Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy
title_short Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy
title_full Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy
title_fullStr Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy
title_full_unstemmed Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy
title_sort prognostic value of unrelated atypical serum immunofixation patterns during multiple myeloma therapy
publisher BMC
series Journal of Hematology & Oncology
issn 1756-8722
publishDate 2012-06-01
description <p>Abstract</p> <p>Autologous stem cell transplantation (ASCT) is the gold standard therapy for suitable multiple myeloma (MM) patients after induction with high dose therapy. To date, the evidence of a reliable marker of prognosis in these cases remains scarce. Our aim was to evaluate appearance of unrelated atypical serum immunofixation patterns (ASIPs) as a marker of prognosis in MM patients submitted to ASCT. We retrospectively analysed data from 65 patients. Interestingly, we observed that presence of ASIPs was associated with longer progression-free survival and longer overall survival. Our results suggested that presence of ASIPs could be a novel marker of good prognosis in MM patients submitted to ASCT.</p>
topic Multiple myeloma
Autologous stem cell transplantation
Marker of prognosis
Serum immunofixation patterns
url http://www.jhoonline.org/content/5/1/33
work_keys_str_mv AT guimaraescristina prognosticvalueofunrelatedatypicalserumimmunofixationpatternsduringmultiplemyelomatherapy
AT bergantimrui prognosticvalueofunrelatedatypicalserumimmunofixationpatternsduringmultiplemyelomatherapy
AT ramalhorenata prognosticvalueofunrelatedatypicalserumimmunofixationpatternsduringmultiplemyelomatherapy
AT coutonuno prognosticvalueofunrelatedatypicalserumimmunofixationpatternsduringmultiplemyelomatherapy
AT guimaraesjoaot prognosticvalueofunrelatedatypicalserumimmunofixationpatternsduringmultiplemyelomatherapy
AT trigofernanda prognosticvalueofunrelatedatypicalserumimmunofixationpatternsduringmultiplemyelomatherapy
_version_ 1725831767419518976